This statistic includes only pharmaceutical companies with a single oncologic drug approved by the Food and Drug Administration (FDA). Values are inflation adjusted for 2017 U.S. dollars.
* Alexion later had two drug approvals in the last quarter of 2015; these drugs are not included in this statistic.
** Compound acquired by the company on this date.
Citation formats
Total R&D costs including costs of capital for select cancer drugs 2017
This statistic shows the total cost of research and development (R&D) including a * percent per annum cost of capital for select cancer drugs that were on the market as of 2017. Alexion Pharmaceuticals' drug Eculizumab had a total R&D cost, including capital, of around **** billion U.S. dollars as of 2017. Total R&D costs without the * percent of annual cost of capital stood at some *** million dollars.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Journal of the American Medical Association. (November 1, 2017). Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 28, 2026, from /statistics/788904/randd-costs-for-select-cancer-drugs-including-capital/
Journal of the American Medical Association. "Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017 (in million U.S. dollars)." Chart. November 1, 2017. ÌÇÐÄÆƽâ°æ. Accessed July 28, 2026. /statistics/788904/randd-costs-for-select-cancer-drugs-including-capital/
Journal of the American Medical Association. (2017). Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 28, 2026. /statistics/788904/randd-costs-for-select-cancer-drugs-including-capital/
Journal of the American Medical Association. "Total R&d Costs including 7 Percent Annual Cost of Capital for Select Cancer Drugs on The Market as of 2017 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 1 Nov 2017, /statistics/788904/randd-costs-for-select-cancer-drugs-including-capital/
Journal of the American Medical Association, Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/788904/randd-costs-for-select-cancer-drugs-including-capital/ (last visited July 28, 2026)
Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017 (in million U.S. dollars) [Graph], Journal of the American Medical Association, November 1, 2017. [Online]. Available: /statistics/788904/randd-costs-for-select-cancer-drugs-including-capital/
